Stocks and Investing Stocks and Investing
Fri, March 8, 2019
Thu, March 7, 2019
Wed, March 6, 2019

David Risinger Downgraded (TEVA) to Hold and Held Target at $17 on, Mar 6th, 2019


Published on 2024-10-26 12:31:08 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $17 on, Mar 6th, 2019.

David has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019
  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019


These are the ratings of the 2 analyists that currently disagree with David


  • Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019
  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019

Contributing Sources